The Primary Endpoint is Success at 180 Days Which is Defined as Alive on the Originally Implanted HeartWare® LVAD or Transplanted or Explanted for Recovery. Patient Must Survive 60 Days Post-explant for Recovery to be Considered Successful.
Survival to 180 Days
Incidence of Adverse Events, Neurocognitive Status and Unanticipated Adverse Device Effects
(and 4 more...)
18 Years and older (Adult, Senior)
September 12, 2008
November 4, 2016
May 2, 2014
Mayo Clinic (Arizona) Phoenix, Arizona, United States
Sharp Memorial Hospital San Diego, California, United States
Stanford University School of Medicine Stanford, California, United States
(and 32 more...)
† Study has passed its completion date and status has not been verified in more than two years.